Effects of glucocorticoids on expression of the fos protooncogene in AtT-20 cells.
Glucocorticoid regulation of expression of the protooncogene fos has been examined in AtT-20 cells at both the RNA and protein levels. When cells were incubated continuously in the presence of dexamethasone, an early (30 min) rise in the expression of fos mRNA was observed, which declined by 1 h, but rose again after 2 h of hormone treatment. Six hours after hormone treatment, fos mRNA levels had returned to control levels in spite of the continued presence of dexamethasone. Serum treatment resulted in a sustained increase in fos mRNA levels; however, the glucocorticoid and serum effects were additive. Dexamethasone and/or serum both increased the steady state levels of fos protein. Glucocorticoid treatment of AtT-20 cells results in complex changes in fos expression, but does not affect their viability or growth rate; these results suggest that fos may play a role in mediation or modulation of glucocorticoid effects other than growth.
Lin
S C
SC
Department of Medicine, University of Arkansas for Medical Sciences, Little Rock 77205.
MacLeod
S
S
Hardin
J W
JW
D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology*; D016762:Genes, fos; D016761:Oncogene Proteins v-fos / Q000032:analysis / Q000276:immunology; D011233:Precipitin Tests; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000032:analysis
D016761:Oncogene Proteins v-fos; D012333:RNA, Messenger; D003907:Dexamethasone; D003513:Cycloheximide